Filing Details
- Accession Number:
- 0001209191-16-115915
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-27 16:18:57
- Reporting Period:
- 2016-04-25
- Filing Date:
- 2016-04-27
- Accepted Time:
- 2016-04-27 16:18:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189846 | L John Bishop | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Chairman Of The Board And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-25 | 110,000 | $8.43 | 194,449 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-25 | 110,000 | $35.50 | 84,449 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2016-04-25 | 110,000 | $0.00 | 110,000 | $8.43 |
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2016-04-25 | 150,000 | $0.00 | 150,000 | $35.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-04-28 | 2016-04-28 | No | 4 | M | Direct |
| 150,000 | 2017-04-25 | 2023-04-25 | No | 4 | A | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Billionaire Hedge Funds
